Clinical Trial Update: Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Clinical trial update indicates imeglimin may provide durable glycemic control in people with Type 2 diabetes, in a Phase 4 study. The study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Imeglimin (imeglimin)

Snippet

Sponsor: National Center for Global Health and Medicine, Japan | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: ACTIVE_NOT_RECRUITING